放射治疗临床试验中MRI用于治疗计划的指南
本文旨在为设计或开展使用MRI进行放疗治疗计划的临床试验提供技术与安全方面的指导,由英国国家放疗试验质量保证组(RTTQA)协作制定。指南强调研究者应在试验方案中纳入影像指导文件,并指出许多建议也适用于MR引导治疗机和临床试验外的常规MRI应用。
要点
- 放疗临床试验方案应包含针对试验的MRI采集、后处理和质量保证的影像指导文件。
- 影像要求的复杂程度取决于试验目的、设计和所用MRI方法。
- 本指南的许多考虑和建议可能也适用于MR引导治疗机及临床试验外的常规应用。
核心结论
- 强烈推荐撰写临床试验方案的研究者将影像指导作为试验文档的一部分,涵盖试验对MRI程序的特定要求。
研究设计与样本
- 本文为指南类文件,由英国国家放疗试验质量保证组(RTTQA)协作制定,未报告具体方法学与证据分级。
诊断标准与关键数值
- 指南未给出具体的敏感度、特异度、AUC、阈值或分级标准,仅提出影像采集、后处理和质量保证的方法学建议。
临床应用与阅片要点
- 研究者设计涉及MRI的放疗临床试验时,应提供充分的影像采集、后处理和质量保证方法信息,使参与中心以一致标准完成MRI。
- 本文包含大量建议,并非所有建议都适用于特定试验,试验设计者须加以考虑。
- 试验设计者须自行判断试验可及性与技术严谨性之间的适当平衡。
- 文中许多考虑和建议可能也适用于MR引导治疗机,临床试验在其中将至关重要;同样,许多建议也适用于临床试验外的常规MRI放疗应用。
局限性
- 本文包含大量建议,并非所有建议都适用于任何特定试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The aim of this article is to propose meaningful guidance covering the technical and safety issues involved when designing or conducting radiotherapy clinical trials that use MRI for treatment planning. The complexity of imaging requirements will depend on the trial aims, design and MRI methods used.The use of MRI within the RT pathway is becoming more prevalent and clinically appropriate as access to MRI increases, treatment planning systems become more versatile and potential indications for MRI-planning in RT are documented. Novel MRI-planning opportunities are often initiated and validated within clinical trials.The guidance in this document is intended to assist researchers designing RT clinical trials involving MRI, so that they may provide sufficient information about the appropriate methods to be used for image acquisition, post-processing and quality assurance such that participating sites complete MRI to consistent standards. It has been produced in collaboration with the National Radiotherapy Trials Quality Assurance Group (RTTQA).As the use of MRI in RT is developed, it is highly recommended for researchers writing clinical trial protocols to include imaging guidance as part of their clinical trial documentation covering the trial-specific requirements for MRI procedures. Many of the considerations and recommendations in this guidance may well apply to MR-guided treatment machines, where clinical trials will be crucial. Similarly, many of these recommendations will apply to the general use of MRI in RT, outside of clinical trials.This document contains a large number of recommendations, not all of which will be relevant to any particular trial. Designers of RT clinical trials must therefore take this into account. They must also use their own judgement as to the appropriate compromise between accessibility of the trial and its technical rigour.
引用
- Johnstone RI, Guerrero-Urbano T, Michaelidou A, et al. Guidance on the use of MRI for treatment planning in radiotherapy clinical trials. Br J Radiol. 2019. PMID: 31724876. doi:10.1259/bjr.20190161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。